CaMKII Mediates TGF beta 1-Induced Fibroblasts Activation and Its Cross Talk with Colon Cancer Cells

Wei Chen,Yanwei Chen,Juan Su,Jian Kang,Yijuan Ding,Wen Ai,Jun Zhang,Hesheng Luo,Ping An
DOI: https://doi.org/10.1007/s10620-021-06847-0
2022-01-01
Digestive Diseases and Sciences
Abstract:Introduction Cancer-associated fibroblasts (CAFs), as the activated fibroblasts in tumor stroma, are important modifiers of tumor progression. TGF beta 1 has been the mostly accepted factor to fuel normal fibroblasts transformation into CAFs. Ca2+/calmodulin-dependent protein kinase II (CaMKII) is thought to play an important role in fibroblasts activation induced by TGF beta 1. The aim of this study is to investigate the potential role of CaMKII in TGF beta 1-induced fibroblasts activation and CAF-like differentiation. Cross talk between CaMKII-dependent fibroblasts and colon cancer in colon cancer progression also was addressed Results Immunostaining demonstrated that in colon cancer stroma, CaMKII overexpressed in stromal CAFs. In vitro, TGF beta 1 increased CAF markers expression in human colon fibroblasts CCD-18Co, but not in CaMKII depletion fibroblasts. CaMKII knockdown by CaMKII shRNA significantly inhibited TGF beta 1-induced fibroblasts activation and CAF-like differentiation. Smad3, AKT, and MAPK were targeted in TGF beta 1-CaMKII-mediated pathway. Human colon cancer cell line HCT-116 activated fibroblasts directly, whereas CaMKII depletion dragged CCD-18Co fibroblasts undergoing CAF-associated trans-differentiation. Furthermore, increased proliferation, migration, and invasion of colon cancer cells were stimulated when co-cultured with normal fibroblasts, but not with CaMKII depletion fibroblasts. Conclusions These findings provide evidence that CaMKII is a critical mediator in TGF beta 1-induced fibroblasts activation and is involved in the cross talk with colon cancer cells. CaMKII is a potentially effective target for future treatment of colon cancer.
What problem does this paper attempt to address?